Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01668030 · ClinicalTrials.gov registry record · Phase 4

Comparison of Wound Bed Establishment in Facial Burns

A Phase 4 study of Burns, sponsored by University of Louisville.

Completed
Registry status
Phase 4
Development phase
10
Enrollment target
1
Study location

NCT01668030: Completed Phase 4 study of Burns, sponsored by University of Louisville.

NCT01668030 is a Phase 4 study of Burns that has completed, run by University of Louisville. The registered enrollment target is 10 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01668030, a Phase 4 study of Burns, has completed, sponsored by University of Louisville.

COMPLETED
Registry status
Phase 4
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Forty percent of patients admitted to the contributing regional burn unit over a five month period received facial burns (n=14). The purpose of this study is to examine if the time until a granulation bed is well established can be decreased be using an enzymatic agent, when compared to a second standard ointment, for patients with partial-thickness facial burns. The current study will use a prospective, experimental study design in which each individual will be their own matched control. That is, each individual will receive both the experimental ointment (one-side of the face) and the standard ointment (other-side of the face). Outcomes measured will be the benefits (e.g., decreased in the time until granulation bed establishment) one ointment achieves in partial-thickness facial burns when compared to a second ointment. Exploratory analyses will examine the relationships among demographic variables, granulation bed establishment time, pain, anxiety, itching, and scarring. That is, testing whether the time until granulation establishment may be associated with an individual's demographic variables, treatment type, pain, anxiety, itching levels, and scarring. Significance for all analysis will be at the 0.05 level. The investigators hypothesize that promoting rapid granulation bed establishment will decrease hospital length of stays, costs, risk of infection, and possibly associated appearance changes. The results from the current study will provide preliminary findings for a future, more sophisticated study.

Primary Outcome

Time it required the subjects treated with two standard ointments to establish a wound bed.

Conditions Studied

Interventions

  • DRUG Enzymatic agent
  • DRUG Bacitracin

Study Locations (1)

Kentucky

  • UofL Health Care - Louisville

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2012-02
Est. Completion 2014-08
Phase Phase 4
University of Louisville

217 total trials

What the finished NCT01668030 record still lists

NCT01668030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 83-participant average among 36 other Burns trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Burns appearing as the primary indexed condition, and to 2 interventions - of which Enzymatic agent is the first listed.

NCT01668030 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT01668030 about?

NCT01668030 is a clinical study titled "Comparison of Wound Bed Establishment in Facial Burns". Forty percent of patients admitted to the contributing regional burn unit over a five month period received facial burns (n=14). The purpose of this study is to examine if the time until a granulation bed is well established can be decreased be using an enzymatic agent, when compared to a second sta...

What is the current status of trial NCT01668030?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2012-02. Estimated completion is 2014-08.

What conditions does trial NCT01668030 study?

This clinical trial studies the following conditions: Burns.

What interventions are being tested in trial NCT01668030?

The interventions under investigation include: Enzymatic agent (DRUG), Bacitracin (DRUG).

Who is sponsoring clinical trial NCT01668030?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01668030 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Burns

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01668030's enrollment target sits among peer trials

10 32nd of 36 higher than 4 of 36 other Burns trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Burns trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01668030, the US trial registry maintained by the National Library of Medicine. NCT01668030 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.